An ACE inhibitor, and the panel beside it.
What lisinopril is, and what tends to come up at the appointment.
Education and visit preparation. Ojava does not prescribe, dose, adjust medication, or decide whether anything here applies to you.
- Blood pressure
- Potassium
- Creatinine and eGFR
- Sodium
Education, and preparation. That is all.
This page explains what a class of medication is and which markers tend to come up in the conversation, so you can walk into your own appointment with better questions. Your clinician and your pharmacist decide everything else.
- No prescription, no dose, and no schedule.
- No advice to start, stop or change anything.
- No judgement about whether a medication is working for you.
What the class is
A class named afterthe enzyme it blocks
ACE stands for angiotensin-converting enzyme, and the class is named for blocking it. That is why the conversation usually covers a blood pressure log and a basic metabolic panel at the same time: the two describe different halves of the same picture.
Drug class
An ACE inhibitor. Several others exist, and a related but distinct class, the ARBs, is often discussed alongside it, so the exact name on your label matters.
What it does
It blocks an enzyme involved in narrowing blood vessels, which affects how relaxed those vessels are and how hard the heart has to work to move blood through them.
Approved uses
High blood pressure, heart failure, and use after a heart attack. The current label for the exact product is the authority on that, not this page.
What comes up
The markers peopletend to bring along
These are the results that often sit near this class of medication in a conversation. Ojava keeps whichever of them are in your own record together, in date order, so the question you ask is about your history rather than a general one.
Blood pressure readings
Home and clinic readings measure the same thing in different settings, which is why both are useful and why the date and time on each one matters.
Potassium
An electrolyte measured on a basic metabolic panel. It comes up often enough in this conversation to be worth having a question ready about.
Creatinine and eGFR
Together they describe how well the kidneys are filtering. They appear on most routine panels and are a common thing to ask about.
Blood urea nitrogen
Another kidney-related value on the same panel. It measures something different from creatinine, which is why the two usually appear side by side.
Sodium
An electrolyte on the same basic panel. It is part of the standard set rather than an extra test, so you likely already have a history of it.
Symptom notes
A persistent cough or lightheadedness are the things people tend to notice. Written down with dates, they give the conversation something concrete.
No target value, no reference band and no reading of whether a medication is working appears on this page. Ojava organizes what you already have and explains what a marker measures. Interpreting your own results is a conversation for your clinician.
Before the visit
Walk in withthe specific question
A good appointment usually turns on one precise question. These are the ones worth having written down, and the record that makes each of them specific.
- What is this medication meant to do for someone in my situation?
- How would you like me to record blood pressure at home, and how often?
- What side effects are worth telling you about, and how quickly?
- Are there interactions with anything else on my list, including supplements?
- How often would you want the metabolic panel repeated?
- What would make you want to revisit this decision?
What your record already holds
- Your medication list, with the dates you noted for each entry.
- Home and clinic blood pressure readings in one series, with times attached.
- Potassium, creatinine and eGFR results in date order, from panels you accepted.
- Your own notes about how you have felt, kept next to the timeline rather than in a separate app.
Sources
What this page stands on.
Official labelling and professional-society guidance, linked so you can read the original rather than take a summary on trust.
DailyMed Drug Labeling
U.S. National Library of Medicine, 2026
Supports official label-backed medication education. Label mentions are not the same as patient-specific safety clearance.
Drug Interactions: What You Should Know
U.S. Food and Drug Administration, 2013
Supports consumer education around drug-drug, drug-food, supplement, and condition interactions. It does not make Ojava a comprehensive interaction checker.
Mixing Medications and Dietary Supplements Can Endanger Your Health
U.S. Food and Drug Administration, 2022
Supports asking a clinician or pharmacist about supplement and medication combinations instead of treating a missing match as safe.
American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults
American Geriatrics Society Beers Criteria Update Expert Panel, 2023
Supports medication-review caution and the idea that certain medication risks depend on age, condition, kidney function, and drug-drug context. It is not a patient-specific safety clearance.
STOPP/START criteria for potentially inappropriate prescribing in older people: version 3
O Mahony, Cherubini, Guiteras, et al., 2023
Supports older-adult medication-review prompts around potentially inappropriate prescriptions and possible prescribing omissions. Ojava does not apply the criteria or classify a patient-specific issue.
Deprescribing Guidelines and Algorithms
Deprescribing.org, 2026
Supports deprescribing conversation preparation with a clinician or pharmacist. Ojava does not stop, taper, substitute, or recommend medication changes.
DailyMed Lisinopril Drug Labels
DailyMed, U.S. National Library of Medicine, 2026
Supports official-label medication education for lisinopril. It does not clear patient-specific safety, dosing, or blood-pressure targets.
2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, Carey, Aronow, et al., 2017
Supports blood-pressure education and clinician-led hypertension evaluation. Ojava does not diagnose hypertension, set targets, or clear safety.
Bring the record,not just the question
Keep your ACE inhibitor history, your own results and your notes in one place, and the next appointment starts from what actually happened rather than from memory.
Your list, your notes
What you take and what you have noticed, held together with the results and documents that sit near them.
In date order
Results line up chronologically, so a question about a change is asked about a real change rather than an impression.
The decision stays with care
Prescribing, dosing, refills, and any change at all remain with your licensed clinician or pharmacist.
This is general educational information about a class of medication, not medical advice, a prescription, or a recommendation. Ojava does not diagnose, prescribe, dose, adjust medication, order labs, or replace your clinician.